ERGOTAMINE TARTRATE AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ergotamine Tartrate And Caffeine, and when can generic versions of Ergotamine Tartrate And Caffeine launch?
Ergotamine Tartrate And Caffeine is a drug marketed by Hikma Intl Pharms and Mikart and is included in two NDAs.
The generic ingredient in ERGOTAMINE TARTRATE AND CAFFEINE is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERGOTAMINE TARTRATE AND CAFFEINE?
- What are the global sales for ERGOTAMINE TARTRATE AND CAFFEINE?
- What is Average Wholesale Price for ERGOTAMINE TARTRATE AND CAFFEINE?
Summary for ERGOTAMINE TARTRATE AND CAFFEINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 1 |
| DailyMed Link: | ERGOTAMINE TARTRATE AND CAFFEINE at DailyMed |
Pharmacology for ERGOTAMINE TARTRATE AND CAFFEINE
| Drug Class | Central Nervous System Stimulant Ergotamine Derivative Methylxanthine |
| Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for ERGOTAMINE TARTRATE AND CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Intl Pharms | ERGOTAMINE TARTRATE AND CAFFEINE | caffeine; ergotamine tartrate | TABLET;ORAL | 040510-001 | Sep 17, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mikart | ERGOTAMINE TARTRATE AND CAFFEINE | caffeine; ergotamine tartrate | TABLET;ORAL | 040590-001 | Sep 16, 2005 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
